HomeTagsMultiple Sclerosis

Multiple Sclerosis

Biotechnology

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

PR Newswire - February 25, 2022

Synaptogenix, Inc., a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced plans to develop Bryostatin-1 for the treatment of multiple sclerosis ("MS"),...

Healthcare

Qynapse to Present New Evidence on the Value of Qyscore

PR Newswire - February 15, 2022

Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present two posters...